CloudMD Announces $10M Bought Deal

This evening CloudMD Software & Services Inc. (CSE: DOC) announced a $10M bought deal with a syndicate of underwriters co-led by Canaccord and Beacon. The underwriters agreed to purchase 14.3M units at a price of C$0.70 per unit with a full warrant priced at $1.00.

The stock has been on a role for the last month reaching a 52 week high of 95c.

The company also states they intend to use the proceeds of the offering for potential M&A activities to support their strategic growth plans and general corporate purposes.

The units will be offered by way of a short form prospectus and expected to close on June 2nd. The company granted the underwriters an option to purchase up to an additional 2.1M units at a price of C$0.70 per unit, exercisable at any time, for a period of 30 days after and including the closing date, which would result in additional proceeds of approximately C$1.5 million.

For full details, read the official company press release here.

The stock was halted all day and last traded at 77c.


FULL DISCLOSURE: CloudMD Software & Services is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover CloudMD Software & Services on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

Why Silver’s Next Move May Be Built on a Much Stronger Base | Mani Alkhafaji – First Majestic Silver

Guanajuato Silver Q1 Earnings: They Finally Post Positive Net Income

We’re in a New Era of Gold Price Discovery | Ryan King – Equinox Gold

Recommended

Silver47 Starts 10,000 Metre Campaign at Flagship Alaska Silver Project

Blue Jay Gold Launches 16,000 Metre Drill Program At Steller

Related News

Nearly 25% Of Household Income In The US Comes From Coronavirus Government Payments

As the US economy crumbled under the weight of the pandemic, unemployment numbers soared, and...

Sunday, August 2, 2020, 11:30:00 AM

Revive Expects To Complete Phase 3 Interim Analysis In December On Bucillamine In Treatment of COVID-19

Revive Therapeutics (CSE: RVV) provided an update on the status of its ongoing phase three...

Monday, October 26, 2020, 10:54:38 AM

Goldman Sachs Projects Strong US Economy In 2021, But Notes Significant Obstacles Ahead

As the US continues to battle its second, significantly more severe wave of the coronavirus...

Friday, November 13, 2020, 12:06:38 PM

US Economy Suffers Significant GDP Decline in First Quarter, Unemployment Levels to Continue Soaring

The US Commerce Department has issued a grim statement regarding the current state of the...

Thursday, April 30, 2020, 06:15:00 AM

Trudeau To Give Finance Minister Morneau Free Reign to Tax and Spend

This evening, Global News broke the news the Trudeau Government is introducing a bill granting...

Monday, March 23, 2020, 06:43:59 PM